13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001315863-26-000153
Total Value
$1.76B
Positions
95
Other Managers
0
Confidential Omitted
No
Holdings (95)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST | 78464A870 | 1,500,000 | $182.9M | 10.42% |
| 2 | APOGEE THERAPEUTICS INC | APGE | 1,234,926 | $93.2M | 5.31% |
| 3 | INSMED INC | INSM | 450,000 | $78.3M | 4.46% |
| 4 | ABIVAX SA | AAVXF | 505,000 | $68.1M | 3.88% |
| 5 | ISHARES TR | 464287556 | 400,000 | $67.5M | 3.85% |
| 6 | VENTYX BIOSCIENCES INC | 92332V107 | 6,484,558 | $58.6M | 3.34% |
| 7 | XENON PHARMACEUTICALS INC | XENE | 1,250,000 | $56.0M | 3.19% |
| 8 | PRAXIS PRECISION MEDICINES I | PRAX | 185,000 | $54.5M | 3.11% |
| 9 | CYTOKINETICS INC | CYTK | 800,000 | $50.8M | 2.90% |
| 10 | SPYRE THERAPEUTICS INC | SYRE | 1,432,591 | $46.9M | 2.67% |
| 11 | WAVE LIFE SCIENCES LTD | WVE | 2,700,000 | $45.9M | 2.62% |
| 12 | AMGEN INC | AMGN | 135,000 | $44.2M | 2.52% |
| 13 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,400,000 | $43.7M | 2.49% |
| 14 | SELECT SECTOR SPDR TR | 81369Y209 | 250,000 | $38.7M | 2.21% |
| 15 | ROIVANT SCIENCES LTD | ROIV | 1,700,000 | $36.9M | 2.10% |
| 16 | ARCELLX INC | ACLX | 523,725 | $34.1M | 1.95% |
| 17 | NUVALENT INC | NUVL | 322,633 | $32.5M | 1.85% |
| 18 | LEXEO THERAPEUTICS INC | LXEO | 3,200,000 | $31.8M | 1.81% |
| 19 | ALKERMES PLC | ALKS | 1,000,000 | $28.0M | 1.59% |
| 20 | FORTE BIOSCIENCES INC | FBRX | 989,490 | $27.0M | 1.54% |
| 21 | TREVI THERAPEUTICS INC | TRVI | 2,150,172 | $26.9M | 1.53% |
| 22 | MINERALYS THERAPEUTICS INC | MLYS | 730,000 | $26.5M | 1.51% |
| 23 | BRIDGEBIO PHARMA INC | BBIO | 320,000 | $24.5M | 1.39% |
| 24 | ORUKA THERAPEUTICS INC | ORKA | 802,342 | $24.3M | 1.39% |
| 25 | TERNS PHARMACEUTICALS INC | TERN | 550,000 | $22.2M | 1.27% |
| 26 | ANAPTYSBIO INC | ANABV | 444,692 | $21.6M | 1.23% |
| 27 | CULLINAN THERAPEUTICS INC | CGEM | 1,932,106 | $20.0M | 1.14% |
| 28 | OMEROS CORP | OMER | 6,525,000 | $19.4M | 1.10% |
| 29 | UNIQURE NV | QURE | 800,000 | $19.1M | 1.09% |
| 30 | AVALO THERAPEUTICS INC | AVTX | 1,051,054 | $19.1M | 1.09% |
| 31 | NURIX THERAPEUTICS INC | NRIX | 967,620 | $18.4M | 1.05% |
| 32 | TAYSHA GENE THERAPIES INC | TSHA | 3,300,000 | $18.1M | 1.03% |
| 33 | MADRIGAL PHARMACEUTICALS INC | MDGL | 31,131 | $18.1M | 1.03% |
| 34 | SAVARA INC | SVRA | 2,797,153 | $16.9M | 0.96% |
| 35 | PROTAGONIST THERAPEUTICS INC | PTGX | 172,125 | $15.0M | 0.86% |
| 36 | CENTESSA PHARMACEUTICALS PLC | CNTA | 600,552 | $15.0M | 0.86% |
| 37 | ESTABLISHMENT LABS HLDGS INC | ESTA | 200,000 | $14.6M | 0.83% |
| 38 | ERASCA INC | ERAS | 3,900,000 | $14.5M | 0.83% |
| 39 | VERA THERAPEUTICS INC | VERA | 250,000 | $12.7M | 0.72% |
| 40 | COGENT BIOSCIENCES INC | COGT | 350,000 | $12.4M | 0.71% |
| 41 | OVID THERAPEUTICS INC | OVID | 7,150,000 | $11.7M | 0.66% |
| 42 | TRAVERE THERAPEUTICS INC | TVTX | 300,000 | $11.5M | 0.65% |
| 43 | JADE BIOSCIENCES INC | JBIO | 714,956 | $11.0M | 0.63% |
| 44 | TRAVERE THERAPEUTICS INC | TVTX | 7,000,000 | $10.0M | 0.57% |
| 45 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 275,000 | $9.6M | 0.55% |
| 46 | CELLDEX THERAPEUTICS INC NEW | CLDX | 350,000 | $9.5M | 0.54% |
| 47 | ZURA BIO LTD | ZURA | 1,813,671 | $9.5M | 0.54% |
| 48 | TANGO THERAPEUTICS INC | TNGX | 1,000,000 | $8.9M | 0.50% |
| 49 | SUTRO BIOPHARMA INC | STRO | 748,382 | $8.7M | 0.49% |
| 50 | REVOLUTION MEDICINES INC | RVMDW | 100,000 | $8.0M | 0.45% |
| 51 | MBX BIOSCIENCES INC | MBX | 250,000 | $7.9M | 0.45% |
| 52 | VIRIDIAN THERAPEUTICS INC | VRDN | 250,000 | $7.8M | 0.44% |
| 53 | ARCUS BIOSCIENCES INC | RCUS | 300,000 | $7.1M | 0.41% |
| 54 | SAGIMET BIOSCIENCES INC | SGMT | 1,148,245 | $6.8M | 0.39% |
| 55 | KARYOPHARM THERAPEUTICS INC | KPTI | 889,575 | $6.5M | 0.37% |
| 56 | CELCUITY INC | CELC | 3,000,000 | $6.5M | 0.37% |
| 57 | ASCENDIS PHARMA A/S | ASND | 30,000 | $6.4M | 0.36% |
| 58 | SUMMIT THERAPEUTICS INC | SMMT | 350,000 | $6.1M | 0.35% |
| 59 | VERRICA PHARMACEUTICALS INC | VRCA | 707,338 | $5.9M | 0.33% |
| 60 | ENGENE HOLDINGS INC | ENGNW | 643,370 | $5.8M | 0.33% |
| 61 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 245,000 | $5.6M | 0.32% |
| 62 | REZOLUTE INC | RZLT | 2,351,144 | $5.5M | 0.32% |
| 63 | AVADEL PHARMACEUTICALS PLC | G29687103 | 250,000 | $5.4M | 0.31% |
| 64 | CLIMB BIO INC | CLYM | 1,300,000 | $5.2M | 0.30% |
| 65 | IMMUNOVANT INC | IMVT | 200,000 | $5.1M | 0.29% |
| 66 | PROQR THRAPEUTICS N V | N71542109 | 2,454,278 | $5.0M | 0.28% |
| 67 | DIANTHUS THERAPEUTICS INC | DNTH | 115,000 | $4.7M | 0.27% |
| 68 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 70,000 | $4.6M | 0.26% |
| 69 | IBIO INC | IBIO | 2,057,200 | $4.0M | 0.23% |
| 70 | NEXTCURE INC | NXTC | 247,294 | $3.5M | 0.20% |
| 71 | CRINETICS PHARMACEUTICALS IN | CRNX | 75,000 | $3.5M | 0.20% |
| 72 | AMGEN INC | AMGN | 10,000 | $3.3M | 0.19% |
| 73 | BELITE BIO INC | BLTE | 20,000 | $3.2M | 0.18% |
| 74 | ARRIVENT BIOPHARMA INC | AVBP | 150,000 | $3.0M | 0.17% |
| 75 | MERSANA THERAPEUTICS INC | 59045L205 | 100,000 | $2.9M | 0.16% |
| 76 | OAKTREE ACQUISITION CORP III | OACCW | 250,000 | $2.7M | 0.15% |
| 77 | ARBUTUS BIOPHARMA CORP | ABUS | 521,900 | $2.5M | 0.14% |
| 78 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 486,684 | $2.4M | 0.14% |
| 79 | ORCHESTRA BIOMED HLDGS INC | OBIO | 572,804 | $2.4M | 0.14% |
| 80 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 300,000 | $2.3M | 0.13% |
| 81 | GERON CORP | GERN | 1,500,000 | $2.0M | 0.11% |
| 82 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 75,000 | $1.7M | 0.10% |
| 83 | LENZ THERAPEUTICS INC | LENZ | 100,000 | $1.6M | 0.09% |
| 84 | KEZAR LIFE SCIENCES INC | KZR | 229,076 | $1.4M | 0.08% |
| 85 | COMPASS PATHWAYS PLC | CMPS | 200,000 | $1.4M | 0.08% |
| 86 | UNIQURE NV | QURE | 50,000 | $1.2M | 0.07% |
| 87 | COGENT BIOSCIENCES INC | COGT | 1,000,000 | $1.2M | 0.07% |
| 88 | PERSPECTIVE THERAPEUTICS INC | CATX | 300,000 | $825,000 | 0.05% |
| 89 | MACROGENICS INC | MGNX | 484,308 | $779,736 | 0.04% |
| 90 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 50,000 | $651,500 | 0.04% |
| 91 | FORTE BIOSCIENCES INC | FBRX | 22,400 | $610,848 | 0.03% |
| 92 | X4 PHARMACEUTICALS INC | XFOR | 145,000 | $580,000 | 0.03% |
| 93 | Q32 BIO INC | QTTB | 27,777 | $92,220 | 0.01% |
| 94 | ADAGIO MED HLDGS INC | 00534B100 | 80,000 | $83,200 | 0.00% |
| 95 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $1,823 | 0.00% |